4 studies found for:    17151364 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
Condition: Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
Intervention: Procedure: Stem cell transplantation
2 Recruiting Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Nilotinib
3 Completed STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
Condition: Leukemia
Interventions: Biological: recombinant interferon alfa;   Drug: cytarabine;   Drug: imatinib mesylate
4 Terminated Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Zileuton

Indicates status has not been verified in more than two years